Tsurikisawa N et al. - Maintenance of the numbers of regulatory T cells in patients with CEP with asthma might inhibit CSS development through the action of cytokines, such as IL-10 and IL-2, produced by CD4+CD25+ or CD4+CD25 T cells. This might be part of a mechanism that influences progression and prognosis in these diseases.